WuXi AppTec and Insilico Medicine link next-generation artificial intelligence and drug discovery

(InSilico Medicine, Inc.) Insilico Medicine has entered into a collaboration agreement with WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company. The two companies will perform series of experiments, where many novel molecules discovered using Insilico Medicine's generative adversarial networks (GAN) and reinforcement learning (RL)-based drug discovery pipelines will be tested at WuXi AppTec.

from EurekAlert! - Social and Behavioral Science https://ift.tt/2HDI9c6